ArticleJournal of hematology & oncology2026

BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88

Yan Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.